Related references
Note: Only part of the references are listed.Mass balance, pharmacokinetics and pharmacodynamics of intravenous HSK3486, a novel anaesthetic, administered to healthy subjects
Yicong Bian et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Biotransformation Pathways and Metabolite Profiles of Oral [14C]Alisertib (MLN8237), an Investigational Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors
Sandeepraj Pusalkar et al.
DRUG METABOLISM AND DISPOSITION (2020)
Impacts of CYP2C19 genetic polymorphisms on bioavailability and effect on platelet adhesion of vicagrel, a novel thienopyridine P2Y12inhibitor
Yifan Zhang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Pharmacokinetics, absorption, metabolism, and excretion of [14C]ivosidenib (AG-120) in healthy male subjects
Chandra Prakash et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Vicagrel enhances aspirin-induced inhibition of both platelet aggregation and thrombus formation in rodents due to its decreased metabolic inactivation
Yu-Meng Jia et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Metabolism and disposition of pyrotinib in healthy male volunteers: covalent binding with human plasma protein
Jian Meng et al.
ACTA PHARMACOLOGICA SINICA (2019)
The role of P2Y12 receptor in ischemic stroke of atherosclerotic origin
Ying Gao et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Pharmacokinetics, Metabolism, and Excretion of [14C] Esaxerenone, a Novel Mineralocorticoid Receptor Blocker in Humans
Makiko Yamada et al.
DRUG METABOLISM AND DISPOSITION (2019)
Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing
Cai Liu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Development and validation of a sensitive and rapid UHPLC-MS/MS method for the simultaneous quantification of the common active and inactive metabolites of vicagrel and clopidogrel in human plasma
Cai Liu et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers
Xiaojiao Li et al.
FRONTIERS IN PHARMACOLOGY (2018)
Arylacetamide Deacetylase Is Involved in Vicagrel Bioactivation in Humans
Jinfang Jiang et al.
FRONTIERS IN PHARMACOLOGY (2017)
The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
Arwa M. Amin et al.
CARDIOLOGY RESEARCH AND PRACTICE (2017)
Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors
Max-Paul Winter et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2017)
Significant Improvement of Metabolic Characteristics and Bioactivities of Clopidogrel and Analogs by Selective Deuteration
Xueyu Xu et al.
MOLECULES (2016)
Species Comparison of Pre-systemic Bioactivation of Vicagrel, a New Acetate Derivative of Clopidogrel
Zhi-xia Qiu et al.
FRONTIERS IN PHARMACOLOGY (2016)
Ticagrelor, prasugrel, or clopidogrel in ST-segment elevation myocardial infarction: which one to choose?
Patricia O. Guimaraes et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
A historical perspective on radioisotopic tracers in metabolism and biochemistry
Graham Lappin
BIOANALYSIS (2015)
Contributions of Intestine and Plasma to the Presystemic Bioconversion of Vicagrel, an Acetate of Clopidogrel
Zhixia Qiu et al.
PHARMACEUTICAL RESEARCH (2014)
Synthesis of the stabilized active metabolite of clopidogrel
Guillaume Bluet et al.
TETRAHEDRON (2014)
Metabolism and disposition of [14C]tivantinib after oral administration to humans, dogs and rats
Takahiro Murai et al.
XENOBIOTICA (2014)
Carboxylesterase 1 as a Determinant of Clopidogrel Metabolism and Activation
Hao-Jie Zhu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Pharmacokinetics and pharmacodynamics of single and multiple doses of prasugrel in healthy native Chinese subjects
Yi-min Cui et al.
ACTA PHARMACOLOGICA SINICA (2012)
Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis
Wen Cai Zhang et al.
CELL (2012)
Cytochromes P450 Catalyze Both Steps of the Major Pathway of Clopidogrel Bioactivation, whereas Paraoxonase Catalyzes the Formation of a Minor Thiol Metabolite Isomer
Patrick M. Dansette et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Radiolabeled Absorption, Distribution, Metabolism, and Excretion Studies in Drug Development: Why, When, and How?
Natalia Penner et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Overcoming Clopidogrel Resistance: Discovery of Vicagrel as a Highly Potent and Orally Bioavailable Antiplatelet Agent
Jiaqi Shan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite
Miho Kazui et al.
DRUG METABOLISM AND DISPOSITION (2010)
Mass defect filter technique and its applications to drug metabolite identification by high-resolution mass spectrometry
Haiying Zhang et al.
JOURNAL OF MASS SPECTROMETRY (2009)
Metabolites in safety testing
Timothy W. Robison et al.
BIOANALYSIS (2009)
An algorithm for thorough background subtraction from high-resolution LC/MS data: application to the detection of troglitazone metabolites in rat plasma, bile, and urine
Haiying Zhang et al.
JOURNAL OF MASS SPECTROMETRY (2008)
A multiple dose study of prasugrel (CS-747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans
Joseph A. Jakubowski et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles
M Huang et al.
ACTA PHARMACOLOGICA SINICA (2005)
Structure and stereochemistry of the active metabolite of clopidogrel
JM Pereillo et al.
DRUG METABOLISM AND DISPOSITION (2002)
Cysteine derivatives as inhibitors for carboxypeptidase A: Synthesis and structure-activity relationships
JD Park et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Share Paper
